Skip to main content
. 2017 Nov 7;4:90–98. doi: 10.1016/j.pvr.2017.10.004

Table 5.

Association between HSIL and hrHPV, HIV and other STIs.

Other infection Other infection only HR-HPV only HIV only HR-HPV + HIV HR-HPV + other HIV + other HR-HPV + HIV + other
HSV 2 OR NA 4.99 NA 14.3 7.85 NA 9.89
95% CI 2.27–11.0 6.20–33.1 2.84–21.7 3.85–25.4
p < 0.001 < 0.001 < 0.001 < 0.001
n = 447 n 11 178 3 88 32 4 42
Syphilis OR NA 4.51 NA 9.83 5.58 NA 18.6
95% CI 2.03–10.1 4.20–23.0 1.33–23.4 5.67–61.0
p < 0.001 < 0.001 0.019 < 0.001
n = 358 n 3 203 7 109 8 0 21
Gonorrhoea OR NA 3.88 NA 10.4 6.45 NA 9.11
95% CI 1.71–8.83 4.32–25.0 2.32–17.9 3.40–24.4
p 0.001 < 0.001 < 0.001 < 0.001
n = 355 n 9 181 6 95 28 1 35
Chlamydia OR NA 3.95 NA 10.3 4.80 NA 7.70
95% CI 1.73–9.02 4.39–24.3 1.78–13.0 2.52–23.5
p < 0.001 < 0.001 0.002 < 0.001
n = 358 n 12 175 5 107 34 2 23
HBV OR NA 8.25 NA 27.7 NA NA 18.2
95% CI 2.90–23.5 7.80–98.3 3.69–89.9
p < 0.001 < 0.001 < 0.001
n = 441 n 1 203 7 98 6 7 25
HCV OR NA 5.66 NA 16.3 NA NA
95% CI 2.10–15.2 5.15–51.9
p 0.001 < 0.001
n = 431 n 8 204 7 115 3 0 13

NA: indicates that there were insufficient cases to permit estimation.

n: the number of samples for whom there was complete data.